to BioTechniques free email alert service to receive content updates.
Eurofins MWG Operon
Three companies from the Eurofins Scientific Group (MWG Biotech, Operon Biotechnologies, and Medigenomix) have merged to become Eurofins MWG Operon, the new global leader for oligos and sequencing. Collectively, we bring 48 years of experience to this enterprise. Operon has offered custom oligos since 1986, MWG has offered custom oligos and sequencing services since 1992, and Medigenomix has offered next-generation sequencing services since 1998.